Department of Biomedical Engineering, Technion - Israel Institute of Technology, Haifa 32000, Israel.
Department of Neonatology, Carmel Medical Center, Haifa, Israel; Faculty of Medicine, Technion- Israel Institute of Technology, Haifa, Israel.
J Biomech. 2021 Jun 9;122:110458. doi: 10.1016/j.jbiomech.2021.110458. Epub 2021 Apr 22.
Liquid plug therapies are commonly instilled in premature babies suffering from infant respiratory distress syndrome (IRDS) by a procedure called surfactant replacement therapy (SRT) in which a surfactant-laden bolus is instilled endotracheally in the neonatal lungs, dramatically reducing mortality and morbidity in neonatal populations. Since data are frequently limited, the optimal method for surfactant delivery has yet to be established towards more standardized guidelines. Here, we explore the dynamics of liquid plug transport using an anatomically-relevant, true-scale in vitro 3D model of the upper airways of a premature infant. We quantify the initial plug's distribution as a function of two underlying parameters that can be clinically controlled; namely, the injection flow rate and the viscosity of the administered fluid. By extracting a homogeneity index (HI), our in vitro results underline how the combination of both high fluid viscosity and injection flow rates may be advantageous in improving homogeneous dispersion. Such outcomes are anticipated to help refine future SRT administration guidelines towards more uniform distribution using more anatomically-realistic 3D in vitro models at true scale of the preterm neonate.
液体塞疗法通常通过表面活性剂替代疗法(SRT)在患有婴儿呼吸窘迫综合征(IRDS)的早产儿中进行,该疗法通过气管内滴注负载表面活性剂的团块,显著降低了新生儿人群的死亡率和发病率。由于数据经常有限,因此尚未确定针对更标准化指南的最佳表面活性剂输送方法。在这里,我们使用早产儿上呼吸道的解剖相关的真实比例的体外 3D 模型来探索液体塞传输的动力学。我们将初始塞的分布量化为两个潜在参数的函数,这两个参数可以在临床上进行控制;即,注射流速和施用药液的粘度。通过提取均匀度指数(HI),我们的体外结果强调了高流体粘度和注射流速的组合如何有助于改善均匀分散。预计这些结果将有助于完善未来的 SRT 管理指南,以使用更真实的早产儿比例的更具解剖学真实性的 3D 体外模型实现更均匀的分布。